Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of CMS-D001 in adults with moderate to severe atopic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CMS-D001

Snippet

Sponsor: Dermavon Holdings Limited | Conditions: Moderate to Severe Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING